1332724-93-2

Upstream product

• 55041-27-5 3,3-bis[4-hydroxy-3-methylphenyl]pentane 
• 13547-70-1 1-chloro-3,3-dimethyl-butan-2-one 
• 1416802-51-1 ethyl 2-(4-(3-(4-hydroxy-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)acetate 
• 105-36-2 ethyl bromoacetate 
• 233268-82-1 1-(4-(3-(4-hydroxy-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)-3,3-dimethylbutan-2-one 

Downstream Products

• 1332724-88-5 (4-{1-ethyl-1-[4-(2-hydroxy-3,3-dimethylbutoxy)-3-methylphenyl]-propyl}-2-methylphenoxy)-acetic acid 
• 1416802-59-9 ethyl 2-(4-(3-(4-((2R)-hydroxy-3,3-dimethylbutoxy)-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)acetate 
• 1416802-61-3 N-hydroxy-2-(4-(3-(4-(2-hydroxy-3,3-dimethylbutoxy)-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)acetamide 
• 1416802-56-6 N-(benzyloxy)-2-(4-(3-(4-(3,3-dimethyl-2-oxobutoxy)-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)acetamide 
• 1416802-57-7 2-(4-(3-(4-(3,3-dimethyl-2-oxobutoxy)-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)-N-hydroxyacetamide 
• 1416802-58-8 ethyl 2-(4-(3-(4-(2-hydroxy-3,3-dimethylbutoxy)-3-methylphenyl)pentan-3-yl)-2-methylphenoxy)acetate 

Relevant academic research and scientific papers

BIS-(ARYL/HETEROARYL)-METHYLENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR TREATING CANCER

The present disclosure relates to novel bis-(aryl/heteroaryl)-methylene compounds of formula (I) having vitamin D receptor agonist and histone deacetylase (HDAC) inhibitory efficacy as well as to methods for reducing or inhibiting the proliferation of can

Novel nonsecosteroidal vitamin D3 carboxylic acid analogs for osteoporosis, and SAR analysis

Novel vitamin D3 analogs with carboxylic acid were explored, focusing on a nonsecosteroidal analog, LG190178, with a bisphenyl skeleton. From X-ray analysis of these analogs with vitamin D receptor (VDR), the carboxyl groups had very unique hyd